OLIG1
Oligodendrocyte transcription factor 1
Also known as: BHLHB6, bHLHe21, OLIG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAK6
- Gene
- OLIG1
- Ensembl
- ENSG00000184221
- Chromosome
- 21
- Canonical length
- 271 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and E-box binding activity. Predicted to be involved in axon development; positive regulation of transcription by RNA polymerase II; and sensory organ development. Predicted to act upstream of or within neuron fate commitment. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
271 residues, UniProt reviewed canonical sequence.
>Q8TAK6|OLIG1
1 MYYAVSQARV NAVPGTMLRP QRPGDLQLGA SLYELVGYRQ PPSSSSSSTS STSSTSSSST
61 TAPLLPKAAR EKPEAPAEPP GPGPGSGAHP GGSARPDAKE EQQQQLRRKI NSRERKRMQD
121 LNLAMDALRE VILPYSAAHC QGAPGRKLSK IATLLLARNY ILLLGSSLQE LRRALGEGAG
181 PAAPRLLLAG LPLLAAAPGS VLLAPGAVGP PDALRPAKYL SLALDEPPCG QFALPGGGAG
241 GPGLCTCAVC KFPHLVPASL GLAAVQAQFS KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OLIG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 228 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 228 nTPM
- hippocampal formation: 225 nTPM
- midbrain: 221 nTPM
- spinal cord: 203 nTPM
- hypothalamus: 163 nTPM
- basal ganglia: 162 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 701 nCPM
- oligodendrocytes: 248 nCPM
- epididymal principal cells: 19 nCPM
- astrocytes: 19 nCPM
- epididymal efferent duct absorptive cells: 14 nCPM
- monocytes: 9 nCPM
Immune cell
- eosinophil: 38 nTPM
- basophil: 12 nTPM
- non-classical monocyte: 2.5 nTPM
- classical monocyte: 2.4 nTPM
- intermediate monocyte: 0.9 nTPM
- total PBMC: 0.6 nTPM
Brain region
- white matter: 311 nTPM
- basal ganglia: 292 nTPM
- midbrain: 270 nTPM
- medulla oblongata: 270 nTPM
- thalamus: 243 nTPM
- cerebral cortex: 226 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.85
- gnomAD pLI
- 0.66
- gnomAD missense Z
- 1.42
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon development
- neuron fate commitment
- oligodendrocyte development
- positive regulation of transcription by RNA polymerase II
- sensory organ development
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- protein dimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Myc-type, basic helix-loop-helix (bHLH) domain
- Helix-loop-helix DNA-binding domain superfamily
- Basic helix-loop-helix transcription factors
- Helix-loop-helix DNA-binding domain
- Oligodendrocyte transcription factor 1, basic helix-loop-helix domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OLIG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OLIG1 as an antibody target. Whether an autoantibody or antibody against OLIG1 could matter depends on whether native OLIG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OLIG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OLIG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...